Cargando…

Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C

INTRODUCTION: Studies in vitro reveal that endothelin-1 (ET-1) activates the α isoform of protein kinase C (PKC-α) in cultures of endothelial cells, thereby deranging cellular integrity. Sepsis and endotoxemia are associated with increased plasma concentrations of ET-1 that induce acute lung injury...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuklin, Vladimir, Kirov, Mikhail, Sovershaev, Mikhail, Andreasen, Thomas, Ingebretsen, Ole C, Ytrehus, Kirsti, Bjertnaes, Lars
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175881/
https://www.ncbi.nlm.nih.gov/pubmed/15987392
http://dx.doi.org/10.1186/cc3497
_version_ 1782124526138556416
author Kuklin, Vladimir
Kirov, Mikhail
Sovershaev, Mikhail
Andreasen, Thomas
Ingebretsen, Ole C
Ytrehus, Kirsti
Bjertnaes, Lars
author_facet Kuklin, Vladimir
Kirov, Mikhail
Sovershaev, Mikhail
Andreasen, Thomas
Ingebretsen, Ole C
Ytrehus, Kirsti
Bjertnaes, Lars
author_sort Kuklin, Vladimir
collection PubMed
description INTRODUCTION: Studies in vitro reveal that endothelin-1 (ET-1) activates the α isoform of protein kinase C (PKC-α) in cultures of endothelial cells, thereby deranging cellular integrity. Sepsis and endotoxemia are associated with increased plasma concentrations of ET-1 that induce acute lung injury (ALI). We recently reported that non-selective ET-1 receptor blockade attenuates ALI in sheep by reducing the endotoxin-induced increase in extravascular lung water index (EVLWI). The aim of this study was to find out whether this attenuation is associated with reduced translocation of PKC-α from the cytosolic to the membrane fraction of lung tissue homogenate. METHODS: Seventeen awake, instrumented sheep were randomly assigned to a sham-operated group (n = 3), a lipopolysaccharide (LPS) group (n = 7) receiving an intravenous infusion of Escherichia coli 15 ng/kg per min for 24 hours, and a tezosentan group (n = 7) subjected to LPS and, from 4 hours, an intravenous injection of tezosentan 3 mg/kg followed by infusion at 1 mg/kg per hour for the reminder of the experiment. Pulmonary micro-occlusion pressure (Pmo), EVLWI, plasma concentrations of ET-1, tumor necrosis factor-a (TNF-a), and interleukin-8 (IL-8) were determined every 4 hours. Western blotting was used to assess PKC-α. RESULTS: In non-treated sheep a positive correlation was found between the plasma concentration of ET-1 and Pmo in the late phase of endotoxemia (12 to 24 hours). A positive correlation was also noticed between Pmo and EVLWI in the LPS and the LPS plus tezosentan groups, although the latter was significantly reduced in comparison with LPS alone. In both endotoxemic groups, plasma concentrations of ET-1, TNF-α, and IL-8 increased. In the LPS group, the cytosolic fraction of PKC-α decreased by 75% whereas the membrane fraction increased by 40% in comparison with the sham-operated animals. Tezosentan completely prevented the changes in PKC-α in both the cytosolic and the membrane fractions, concomitantly causing a further increase in the plasma concentrations of ET-1, TNF-α, and IL-8. CONCLUSION: In endotoxemic sheep, ET-1 receptor blockade alleviates lung injury as assessed by a decrease in EVLWI paralleled by a reduction in Pmo and the prevention of activation of PKC-α.
format Text
id pubmed-1175881
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-11758812005-07-17 Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C Kuklin, Vladimir Kirov, Mikhail Sovershaev, Mikhail Andreasen, Thomas Ingebretsen, Ole C Ytrehus, Kirsti Bjertnaes, Lars Crit Care Research INTRODUCTION: Studies in vitro reveal that endothelin-1 (ET-1) activates the α isoform of protein kinase C (PKC-α) in cultures of endothelial cells, thereby deranging cellular integrity. Sepsis and endotoxemia are associated with increased plasma concentrations of ET-1 that induce acute lung injury (ALI). We recently reported that non-selective ET-1 receptor blockade attenuates ALI in sheep by reducing the endotoxin-induced increase in extravascular lung water index (EVLWI). The aim of this study was to find out whether this attenuation is associated with reduced translocation of PKC-α from the cytosolic to the membrane fraction of lung tissue homogenate. METHODS: Seventeen awake, instrumented sheep were randomly assigned to a sham-operated group (n = 3), a lipopolysaccharide (LPS) group (n = 7) receiving an intravenous infusion of Escherichia coli 15 ng/kg per min for 24 hours, and a tezosentan group (n = 7) subjected to LPS and, from 4 hours, an intravenous injection of tezosentan 3 mg/kg followed by infusion at 1 mg/kg per hour for the reminder of the experiment. Pulmonary micro-occlusion pressure (Pmo), EVLWI, plasma concentrations of ET-1, tumor necrosis factor-a (TNF-a), and interleukin-8 (IL-8) were determined every 4 hours. Western blotting was used to assess PKC-α. RESULTS: In non-treated sheep a positive correlation was found between the plasma concentration of ET-1 and Pmo in the late phase of endotoxemia (12 to 24 hours). A positive correlation was also noticed between Pmo and EVLWI in the LPS and the LPS plus tezosentan groups, although the latter was significantly reduced in comparison with LPS alone. In both endotoxemic groups, plasma concentrations of ET-1, TNF-α, and IL-8 increased. In the LPS group, the cytosolic fraction of PKC-α decreased by 75% whereas the membrane fraction increased by 40% in comparison with the sham-operated animals. Tezosentan completely prevented the changes in PKC-α in both the cytosolic and the membrane fractions, concomitantly causing a further increase in the plasma concentrations of ET-1, TNF-α, and IL-8. CONCLUSION: In endotoxemic sheep, ET-1 receptor blockade alleviates lung injury as assessed by a decrease in EVLWI paralleled by a reduction in Pmo and the prevention of activation of PKC-α. BioMed Central 2005 2005-03-14 /pmc/articles/PMC1175881/ /pubmed/15987392 http://dx.doi.org/10.1186/cc3497 Text en Copyright © 2005 Kuklin et al.; licensee BioMed Central Ltd.
spellingShingle Research
Kuklin, Vladimir
Kirov, Mikhail
Sovershaev, Mikhail
Andreasen, Thomas
Ingebretsen, Ole C
Ytrehus, Kirsti
Bjertnaes, Lars
Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title_full Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title_fullStr Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title_full_unstemmed Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title_short Tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase C
title_sort tezosentan-induced attenuation of lung injury in endotoxemic sheep is associated with reduced activation of protein kinase c
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175881/
https://www.ncbi.nlm.nih.gov/pubmed/15987392
http://dx.doi.org/10.1186/cc3497
work_keys_str_mv AT kuklinvladimir tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT kirovmikhail tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT sovershaevmikhail tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT andreasenthomas tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT ingebretsenolec tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT ytrehuskirsti tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec
AT bjertnaeslars tezosentaninducedattenuationoflunginjuryinendotoxemicsheepisassociatedwithreducedactivationofproteinkinasec